Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
616 lung adenocarcinoma (LUAD) and 544 lung squamous cell carcinoma (LUSC) patient mutational profiles from TCGA were analyzed by Ankur Datta, with results last updated in April 2026. The study focuses on specific mutations at the His179 residue in the TP53 zinc-binding motif, evaluating their structural impact via molecular dynamics simulations. It reports TP53 mutations in 50% of LUAD and 81% of LUSC cases, with C > A as the predominant substitution.
Data is provided in a DOCX file format, which may require conversion for computational analysis.